Key result
Postoperative VTE after joint replacement linked to ~3-4x higher mortality, increased rehospitalization, and bleeding.
Why the study?
Does postoperative VTE increase mortality, rehospitalization, bleeding, and healthcare costs in Medicare recipients undergoing THR or TKR?
Cohort (n=170,047)
Yes
Does postoperative VTE increase mortality, rehospitalization, bleeding, and healthcare costs in Medicare recipients undergoing THR or TKR?
Postoperative VTE after major orthopedic surgery is associated with significantly increased mortality, bleeding, rehospitalization, and healthcare costs among Medicare beneficiaries.
Answers are grounded in this paper and cite their sources.
May prompt closer VTE surveillance after hip/knee replacement in Medicare patients; leaves open whether intensified prophylaxis improves survival or reduces costs.
PURPOSE: The impact of postoperative venous thromboembolism (VTE) during initial hospitalization for total hip replacement (THR) or total knee replacement (TKR) surgery was assessed. METHODS: Using Medicare Provider Analysis and Review files, patients who underwent THR, TKR, or hip fracture surgery from 2005 to 2007 were identified using appropriate procedure codes from the International Classification of Diseases, 9th Revision, Clinical Modification. Medicare managed care patients were excluded from the study. Eligible patients were classified as having had deep venous thrombosis (DVT), pulmonary embolism (PE), DVT and PE, or no VTE during their initial hospitalization. Risk adjustment was performed using propensity score matching. Medicare cost, cost to beneficiaries, and cost to primary payers were analyzed to determine risk-adjusted differences in outcome measures, including mortality, rehospitalization, bleeding, length of stay, and total health care expenditures related to VTE events. RESULTS: A total of 170,047 patients were identified. Postoperative VTE events occurred in 3,014 patients (1.77%) during their initial hospitalization. Risk-adjusted mortality rates were three to four times higher for patients with VTE compared with those without VTE. Patients with VTE were more likely to be rehospitalized and experience bleeding within 30 days. Risk-adjusted differences in annual mean cost, including Medicare cost and costs to beneficiaries and primary payers, were significantly greater for patients with VTE. CONCLUSION: Patients who developed VTE after THR or TKR had a higher likelihood of mortality, bleeding, and rehospitalization; were hospitalized longer; and incurred higher costs to Medicare, Medicare beneficiaries, and private payers compared with patients without VTE.
No takes yet. Share an insight, caveat, or question.
Başer et al. (2010) conducted a cohort in Total hip replacement or total knee replacement surgery (n=170,047). Postoperative venous thromboembolism (VTE) vs. No VTE was evaluated on Mortality, rehospitalization, bleeding, length of stay, and total health care expenditures. Postoperative VTE after total hip or knee replacement was associated with 3 to 4 times higher risk-adjusted mortality, increased 30-day rehospitalization and bleeding, and higher costs.
Synapse has enriched 10 related papers. Consider them for comparative context: